New research on cannabis and ketamine‐buprenorphine released at APA annual meeting

New research on the relationship between cannabis and psychosis was released, and a presentation on how low‐dose buprenorphine combined with ketamine reduced suicidality in adults with major depressive disorder was published and presented at the annual meeting of the American Psychiatric Association (APA).

Authors

Publication Details

Journal
Alcoholism & Drug Abuse Weekly
Published
2026-05-21
DOI
https://doi.org/10.1002/adaw.34924
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New research on cannabis and ketamine‐buprenorphine released at APA annual meeting

Alison Knopf
Alcoholism & Drug Abuse Weekly
Treatment of Major Depression
article

New research on cannabis and ketamine‐buprenorphine released at APA annual meeting

Alison Knopf
article en

Abstract

New research on the relationship between cannabis and psychosis was released, and a presentation on how low‐dose buprenorphine combined with ketamine reduced suicidality in adults with major depressive disorder was published and presented at the annual meeting of the American Psychiatric Association (APA).

Alcoholism & Drug Abuse WeeklyVol. 38(21)
Good health and well-being
Openalex Percentile: Top 7%
Treatment of Major Depression
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.